Gene · 7130
Papers2,523
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
541 to 560 of 2,523
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Pathophysiological and Therapeutic Roles of Fascial Hyaluronan in Obesity-Related Myofascial Disease. | Int J Mol Sci | 2022 | 36233143 | PubTator, text mining | PubMed |
| Diversity of Extracellular Vesicles in Human Follicular Fluid: Morphological Analysis and Quantification. | Int J Mol Sci | 2022 | 36232981 | PubTator, text mining | PubMed |
| Selenium-Stimulated Exosomes Enhance Wound Healing by Modulating Inflammation and Angiogenesis. | Int J Mol Sci | 2022 | 36232844 | PubTator, text mining | PubMed |
| Comprehensive analysis reveals potential hub genes and therapeutic drugs in an acquired lymphedema model. | Gland Surg | 2022 | 36221279 | PubTator, text mining | PubMed |
| Soluble ANPEP Released From Human Astrocytes as a Positive Regulator of Microglial Activation and Neuroinflammation: Brain Renin-Angiotensin System in Astrocyte-Microglia Crosstalk. | Mol Cell Proteomics | 2022 | 36220603 | PubTator, text mining | PubMed |
| Current approaches for the regeneration and reconstruction of ocular surface in dry eye. | Front Med (Lausanne) | 2022 | 36213677 | PubTator, text mining | PubMed |
| Recent advances to enhance the immunomodulatory potential of mesenchymal stem cells. | Front Immunol | 2022 | 36211399 | PubTator, text mining | PubMed |
| GLUD1 suppresses renal tumorigenesis and development via inhibiting PI3K/Akt/mTOR pathway. | Front Oncol | 2022 | 36203437 | PubTator, text mining | PubMed |
| Identification of potential biomarkers and pathogenesis in neutrophil-predominant severe asthma: A comprehensive bioinformatics analysis. | Medicine (Baltimore) | 2022 | 36197221 | PubTator, text mining | PubMed |
| TNFα and IFNγ rapidly activate PI3K-AKT signaling to drive glycolysis that confers mesenchymal stem cells enhanced anti-inflammatory property. | Stem Cell Res Ther | 2022 | 36195887 | PubTator, text mining | PubMed |
| Strategies to improve the effect of mesenchymal stem cell therapy on inflammatory bowel disease. | World J Stem Cells | 2022 | 36188115 | PubTator, text mining | PubMed |
| MicroRNAs in the epigenetic regulation of disease progression in Parkinson's disease. | Front Cell Neurosci | 2022 | 36187290 | PubTator, text mining | PubMed |
| Efficacy and safety of small extracellular vesicle interventions in wound healing and skin regeneration: A systematic review and meta-analysis of animal studies. | Theranostics | 2022 | 36185607 | PubTator, text mining | PubMed |
| Identification of molecular subtypes based on inflammatory response in lower-grade glioma. | Inflamm Regen | 2022 | 36180938 | PubTator, text mining | PubMed |
| Single-cell analysis reveals heterogeneity of juvenile idiopathic arthritis fibroblast-like synoviocytes with implications for disease subtype. | Arthritis Res Ther | 2022 | 36167601 | PubTator, text mining | PubMed |
| Molecular mechanisms of Biyu decoction as treatment for psoriasis: A network pharmacology and molecular docking study. | World J Clin Cases | 2022 | 36158000 | PubTator, text mining | PubMed |
| Drug-Disease Severity and Target-Disease Severity Interaction Networks in COVID-19 Patients. | Pharmaceutics | 2022 | 36145576 | PubTator, text mining | PubMed |
| Involvement of Inflammation and Its Resolution in Disease and Therapeutics. | Int J Mol Sci | 2022 | 36142625 | PubTator, text mining | PubMed |
| A Genome-Wide Association Study of Genetic Variants of Apolipoprotein A1 Levels and Their Association with Vitamin D in Korean Cohorts. | Genes (Basel) | 2022 | 36140721 | PubTator, text mining | PubMed |
| Ramelteon Reduces Oxidative Stress by Maintenance of Lipid Homeostasis in Porcine Oocytes. | Antioxidants (Basel) | 2022 | 36139716 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7130/papers?page=28